Phathom director exercises options, receives RSUs
Phathom Pharmaceuticals director Asit Parikh reported equity compensation and an option exercise that increased his share holdings.
Rhea-AI Filing Summary
Phathom Pharmaceuticals director Asit Parikh reported equity compensation and an option exercise that increased his share holdings. He exercised options to acquire 17,500 shares of common stock at $4.95 per share, and the corresponding right to buy 17,500 shares was surrendered back to the company.
Parikh also received a grant of 24,122 Restricted Stock Units under the Non-Employee Director Compensation Program. These RSUs vest in full on the earlier of the first anniversary of the May 19, 2026 grant date or the next annual stockholder meeting, subject to continued board service. After these transactions, he holds 52,122 shares directly and 120,500 shares indirectly through a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Parikh Asit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock (Right to Buy) | 17,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 17,500 | $4.95 | $87K |
| Grant/Award | Common Stock | 24,122 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock (Right to Buy) — 0 contracts (Direct);
Common Stock — 52,122 shares (Direct);
Common Stock — 120,500 shares (Indirect, by Trust)
Footnotes (1)
- F1. The Restricted Stock Units ("RSUs") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Key Figures
Option exercise shares: 17,500 shares
Option exercise price: $4.95/share
RSU grant size: 24,122 units
+3 more
6 metrics
Option exercise shares
17,500 shares
Common Stock acquired via option exercise at $4.95 on May 20, 2026
Option exercise price
$4.95/share
Exercise or conversion price for 17,500-share option
RSU grant size
24,122 units
Restricted Stock Units granted May 19, 2026 to non-employee director
Direct holdings after transactions
52,122 shares
Common Stock directly owned by Asit Parikh after reported transactions
Indirect holdings via trust
120,500 shares
Common Stock indirectly owned by trust as of May 19, 2026
Option expiration date
June 2, 2035
Original expiration date of exercised 17,500-share option
Key Terms
Restricted Stock Units ("RSUs"), Non-Employee Director Compensation Program, disposition to issuer, contingent right to receive one share, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"The Restricted Stock Units ("RSUs") were granted on May 19, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Employee Director Compensation Program financial
"pursuant to the Issuer's Non-Employee Director Compensation Program"
disposition to issuer financial
"transaction_code_description":"Disposition to issuer""
indirect ownership by Trust financial
"total_shares_following_transaction":"120500.0000" ... "nature_of_ownership":"by Trust""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did PHAT director Asit Parikh report?
Asit Parikh reported exercising options for 17,500 Phathom shares at $4.95 and receiving 24,122 Restricted Stock Units as a board compensation grant. He also reported updated direct and indirect common stock holdings after these transactions.
What RSU grant did Asit Parikh receive from Phathom Pharmaceuticals (PHAT)?
Parikh received 24,122 Restricted Stock Units under Phathom’s Non-Employee Director Compensation Program. Each RSU represents one common share, with 100% vesting on the earlier of the first anniversary of the May 19, 2026 grant or the next annual stockholder meeting.
When do Asit Parikh’s newly granted Phathom (PHAT) RSUs vest?
All 24,122 RSUs vest on the earlier of the first anniversary of the May 19, 2026 grant date or the next annual meeting of stockholders, provided Parikh continues serving on Phathom’s board through that vesting date.
What happened to Asit Parikh’s Phathom stock options after the exercise?
The option giving a right to buy 17,500 Phathom shares at $4.95 was exercised and then fully disposed of back to the issuer. After this disposition, no shares remain subject to that particular option grant in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
